Top Markets
Coin of the day
Polydex Pharmaceuticals Limited Polydex Pharmaceuticals Limited

Polydex Pharmaceuticals Limited

POLXF
Rang in Aktien #33819
Polydex Pharmaceuticals Limited (PPL), a Toronto, Canada-based company, was... Polydex Pharmaceuticals Limited (PPL), a Toronto, Canada-based company, was incorporated in 1979 and initially operated as Polydex Chemicals Limited before adopting its current name in March 1984. PPL specializes in the research, development, manufacturing, and global marketing of biotechnology-derived products for the human pharmaceutical sector. Beyond its human health focus, PPL also produces vital pharmaceutical intermediates for the veterinary industry. Its core product line centers on dextran and its various derivatives. Notable examples include iron dextran, a compound administered to newborn pigs to combat anemia, and dextran sulphate, a specialized chemical derivative crucial for biotechnology applications and the broader pharmaceutical sector. Furthermore, the company is actively developing Ushercell, a high molecular weight cellulose sulphate. This innovative product is designed for topical vaginal use, primarily aimed at preventing the transmission of AIDS and other sexually transmitted diseases, as well as unplanned pregnancies. PPL's portfolio further extends to supplying ferric hydroxide and hydrogenated dextran solutions. Products reach the market through a combination of independent distributors, wholesalers, and direct sales channels to various companies.
Aktienkurs
$1.99
Zuletzt synchronisiert: 2023-08-07
Marktkapitalisierung
$6.82M
Veränderung (1 Tag)
0.30%
Veränderung (1 Jahr)
0.00%
Land
CA
Handel Polydex Pharmaceuticals Limited (POLXF)

Kategorie

Preis POLXF mit Marktkapitalisierung von B
Polydex Pharmaceuticals Limited Polydex Pharmaceuticals Limited
POLXF
$1.99
Marktkapitalisierung von Polydex Pharmaceuticals Limited(POLXF)
Marktkapitalisierung: $6.82M
Mit Stand August 2026 hat Polydex Pharmaceuticals Limited eine Marktkapitalisierung von $6.82M. Das macht Polydex Pharmaceuticals Limited laut unseren Daten zum 33819th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Polydex Pharmaceuticals Limited von 1981 bis 2026
POLXF im Vergleich zu den Top 5 der beliebtesten stocks
Preis für POLXF Vermögenswert B Marktkapitalisierung von B Ergebnisse
Polydex Pharmaceuticals Limited Polydex Pharmaceuticals Limited
$1,588,258 $6.82M
$5.452T +79,972,615.54%
Polydex Pharmaceuticals Limited Polydex Pharmaceuticals Limited
$1,308,049 $6.82M
$4.490T +65,863,402.81%
Polydex Pharmaceuticals Limited Polydex Pharmaceuticals Limited
$1,212,608 $6.82M
$4.162T +61,057,689.50%
Polydex Pharmaceuticals Limited Polydex Pharmaceuticals Limited
$1,071,006 $6.82M
$3.676T +53,927,673.47%
Polydex Pharmaceuticals Limited Polydex Pharmaceuticals Limited
$825,332 $6.82M
$2.833T +41,557,421.77%